Main Street Exits NRI Clinical Research and SambaSafety; Buyers Velocity Clinical Research and Stone Point Capital

September 21, 2021

Main Street Capital Corporation fully exited its investments in NRI Clinical Research, LLC (sold to sponsor-backed Velocity Clinical Research) and realized additional gains on the sale of its remaining equity interest in SambaSafety following Stone Point Capital's acquisition. Main Street reported realized gains of approximately $8.8 million on NRI and $4.5 million on SambaSafety as part of these portfolio exits.

Buyers
Velocity Clinical Research, Stone Point Capital
Targets
NRI Clinical Research, LLC, SambaSafety (Safety Holdings, Inc.)
Sellers
Main Street Capital Corporation
Location
United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.